Le Lézard
Classified in: Business
Subjects: SHAREHOLDER RIGHTS PLANS, v

RioCan Real Estate Investment Trust Announces June 2023 Distribution


TORONTO, Ontario, June 15, 2023 (GLOBE NEWSWIRE) -- RioCan Real Estate Investment Trust ("RioCan") (TSX: REI.UN) today announced a distribution of 9 cents per unit for the month of June. The distribution will be payable on July 10, 2023 to unitholders of record as at June 30, 2023.

About RioCan
RioCan is one of Canada's largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at March 31, 2023, our portfolio is comprised of 191 properties with an aggregate net leasable area of approximately 33.5 million square feet (at RioCan's interest) including office, residential rental and 11 development properties. To learn more about us, please visit www.riocan.com.



These press releases may also interest you

at 02:09
In a groundbreaking collaboration between world-renowned three-Michelin-star Chef Corey Lee and Hyundai Motor Group Innovation Center Singapore (HMGICS), Na...

at 02:00
("Amaroq" or the "Corporation" or the "Company") Q1 2024 Financial Results TORONTO, ONTARIO ? 14 May 2024 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and...

at 02:00
Beneath a lush vine canopy, a captivating card gallery highlights Goldpac's strengthened capabilities towards environmental developments. Showcased eco-friendly materials include recycled PVC, PLA, PETG, metal, and other inventive materials. Premium...

at 02:00
Ndustrial, the AI-powered energy intensity platform for industry, today announced the initial close of $18.5 million in a Series B funding round co-led by ABB and GS Energy, joining existing partners such as Clean Energy Ventures and ENGIE New...

at 02:00
Amidst an era marked by swift...

at 02:00
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study.  Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital,...



News published on and distributed by: